Compare TRI & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRI | IDXX |
|---|---|---|
| Founded | 1851 | 1983 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.2B | 57.1B |
| IPO Year | N/A | 1991 |
| Metric | TRI | IDXX |
|---|---|---|
| Price | $122.01 | $691.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 10 |
| Target Price | $190.67 | ★ $700.50 |
| AVG Volume (30 Days) | ★ 941.3K | 430.3K |
| Earning Date | 02-05-2026 | 02-02-2026 |
| Dividend Yield | ★ 1.98% | N/A |
| EPS Growth | N/A | ★ 21.65 |
| EPS | 3.88 | ★ 12.60 |
| Revenue | ★ $7,376,000,000.00 | $4,167,411,000.00 |
| Revenue This Year | $4.06 | $12.15 |
| Revenue Next Year | $7.75 | $8.72 |
| P/E Ratio | ★ $30.96 | $55.27 |
| Revenue Growth | 2.96 | ★ 8.39 |
| 52 Week Low | $118.64 | $356.14 |
| 52 Week High | $218.42 | $769.98 |
| Indicator | TRI | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 33.01 | 44.93 |
| Support Level | $118.64 | $681.00 |
| Resistance Level | $129.89 | $709.24 |
| Average True Range (ATR) | 3.13 | 17.53 |
| MACD | -0.61 | -1.26 |
| Stochastic Oscillator | 25.07 | 42.89 |
Thomson Reuters is a leading global provider of business information services, delivering trusted data, technology, and expertise to professionals across legal, tax, accounting, risk, compliance, and the news and media sectors. Headquartered in Toronto, Canada, the company combines deep domain knowledge with data and software solutions to help clients make informed decisions, manage complexity, and drive efficiency. Thomson Reuters serves legal and accounting/tax professionals, corporations, and governments worldwide, but around 75% of revenue is generated in the US. The company is known for flagship products such as Westlaw, UltraTax CS, and Reuters News.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.